1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
62C6435EAE5F86AE700258DE7004261C0
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-launch-investment-strategy-launch-excellence
18
19
20216.73.216.90
21
22
23emed24.net
24/bestp/domrep.nsf
25RAS




» Products & Services » » Product Launch » Resource Allocation

White Paper: Strategic Resourcing for Launch Market Leadership

Whitepaper Image

ID: BEB-103


Pages/Slides: 10


Published: 2026


Delivery Format: PDF


 

License Options:


Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
Market leadership is no longer won at launch—it is built years earlier. Today’s most successful launches are shaped through deliberate, early investment decisions that establish market readiness, align stakeholders, and accelerate uptake from day one.

This white paper examines how leading organizations are rethinking pre-launch investment strategy to drive stronger launch outcomes. Drawing on benchmarking evidence, it highlights the clear divide between leaders that front-load investment, align spend to asset value, and tailor resourcing to market conditions—and laggards that continue to rely on late-stage spending surges that increasingly fail to deliver impact.

Post-COVID market dynamics have only intensified this shift. Stakeholders now expect earlier engagement, more compelling evidence narratives, and tighter integration across Medical and Commercial teams. As a result, launch success depends less on how much is spent at launch—and more on when, where, and how effectively resources are deployed across the pre-launch window.

The findings and benchmarks examined in this white paper include:

  • How top-performing organizations front-load investment to shape market readiness, accelerate early uptake, and reduce launch risk
  • The role of value-based resourcing, with spend aligned to Peak Year Sales Forecast (PYSF) to ensure proportional and effective investment
  • How leading teams tailor pre-launch investment strategies based on market-entry archetype, rather than applying one-size-fits-all models
Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research; Communications


Companies Profiled:
Pharma; Biotech; Medical Device Companies